These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38743600)

  • 21. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
    Croop R; Goadsby PJ; Stock DA; Conway CM; Forshaw M; Stock EG; Coric V; Lipton RB
    Lancet; 2019 Aug; 394(10200):737-745. PubMed ID: 31311674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Efficacy of Oral Calcitonin-Gene-Related Peptide Antagonists for the Treatment of Acute Migraine: Updated Meta-analysis.
    Ha DK; Kim MJ; Han N; Kwak JH; Baek IH
    Clin Drug Investig; 2021 Feb; 41(2):119-132. PubMed ID: 33426614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rimegepant Orally Disintegrating Tablet for Acute Migraine Treatment: A Review.
    DeFalco AP; Lazim R; Cope NE
    Ann Pharmacother; 2021 May; 55(5):650-657. PubMed ID: 32909437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect and Safety of 5-HT
    Gu P; Chen C; Wu Q; Dong C; Wang T; Wan Q; Dong X
    Biomed Res Int; 2021; 2021():6663591. PubMed ID: 34660796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta-analysis of the efficacy and safety of randomized controlled trials.
    Gui T; Li H; Zhu F; Wang Q; Zhou X; Xue Q
    Headache; 2022 Nov; 62(10):1281-1292. PubMed ID: 36373822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety.
    Lattanzi S; Brigo F; Trinka E; Vernieri F; Corradetti T; Dobran M; Silvestrini M
    Drugs; 2019 Mar; 79(4):417-431. PubMed ID: 30793254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan (oral route of administration) for acute migraine attacks in adults.
    Derry CJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
    Lipton RB; Croop R; Stock EG; Stock DA; Morris BA; Frost M; Dubowchik GM; Conway CM; Coric V; Goadsby PJ
    N Engl J Med; 2019 Jul; 381(2):142-149. PubMed ID: 31291516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
    Cui XP; Ye JX; Lin H; Mu JS; Lin M
    Pain Pract; 2015 Feb; 15(2):124-31. PubMed ID: 24382126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gepants - a long way to cure: a narrative review.
    Altamura C; Brunelli N; Marcosano M; Fofi L; Vernieri F
    Neurol Sci; 2022 Sep; 43(9):5697-5708. PubMed ID: 35650458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
    Lipton RB; Dodick DW; Ailani J; Lu K; Finnegan M; Szegedi A; Trugman JM
    JAMA; 2019 Nov; 322(19):1887-1898. PubMed ID: 31742631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
    Law S; Derry S; Moore RA
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials.
    Hutchinson S; Dodick DW; Treppendahl C; Bennett NL; Yu SY; Guo H; Trugman JM
    Neurol Ther; 2021 Jun; 10(1):235-249. PubMed ID: 33608814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
    Dodick DW; Lipton RB; Ailani J; Halker Singh RB; Shewale AR; Zhao S; Trugman JM; Yu SY; Viswanathan HN
    Headache; 2020 Apr; 60(4):686-700. PubMed ID: 32073660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
    Poolsup N; Leelasangaluk V; Jittangtrong J; Rithlamlert C; Ratanapantamanee N; Khanthong M
    J Clin Pharm Ther; 2005 Dec; 30(6):521-32. PubMed ID: 16336284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CGRP receptor antagonists (gepants).
    Younis S; Latysheva NV; Danilov AB; Ashina M
    Handb Clin Neurol; 2024; 199():51-66. PubMed ID: 38307667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.